The Patent Finder

Merck & Cie KG

Also on record
Records under this name other than patents Merck & Cie KG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Merck & Cie KG

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,344,14018F-LABELLED Folates
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,315,50618F-LABELLED Folates
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,180,128Stable pharmaceutical compositions of 5,10-methylene tetrahydrofolate
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,265,746Method for cell-specific targeting
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,727,987Crystalline Forms of ( 6R)-L-ERYTHRO-TETRAHYDROBIOPTERIN Dihydrochloride
Formerly held
Term ended
Term ended Oct 14, 2025 · High confidence
Term endedTerm ended Oct 14, 2025High confidence
US 8,318,745Crystalline Forms of (6R)-L-ERYTHRO-TETRAHYDROBIOPTERIN Dihydrochloride
Formerly held
Term ended
Term ended Nov 17, 2024 · High confidence
Term endedTerm ended Nov 17, 2024High confidence
US 8,344,139Process for Preparing Crystalline Polymorphic Forms of (6R)-L-ERYTHRO-TETRAHYDROBIOPTERIN Dihydrochloride
Formerly held
Term ended
Term ended Nov 17, 2024 · High confidence
Term endedTerm ended Nov 17, 2024High confidence
US 6,441,168Stable crystalline salts of 5-methyltetrahydrofolic acid
Formerly held
Term ended
Term ended Jul 30, 2022 · USPTO record
Term endedTerm ended Jul 30, 2022USPTO record
US 6,858,731Process for the Preparation of Pure Stereoisomers of Tetrahydrofolic Acid Ester Salts and Tetrahydrofolic Acid by Fractionated Crystallisation of Tetrahydrofolic Acid Ester Salts
Formerly held
Term ended
Term ended Jul 19, 2020 · High confidence
Term endedTerm ended Jul 19, 2020High confidence
US 7,816,525Process for the Preparation of Optically Pure Tetrahydropterins and Derivatives, and Specifically of Optically Pure Tetrahydrofolic Acid and Derivatives Thereof, by Stereospecific Hydrogenation
Formerly held
Term ended
Term ended Jul 12, 2020 · High confidence
Term endedTerm ended Jul 12, 2020High confidence
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited